Clinical trial
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic…
NCT00012389 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00012389 |
|---|---|
| Title | Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer |
| Official title | A Multicenter, Open-Label, Randomized, Two-Arm Study of Irinotecan (CPT-11) Versus the Combination of Oxaliplatin + Irinotecan (CPT-11) as Second-Line Treatment of Metastatic Colorectal Carcinoma |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride, oxaliplatin |
| Start date | Dec 1, 2000 |
| Completion | Oct 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | Brazil, Canada, Czechia, Hungary, Poland, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: